[AKRO] YoY Quarter Result on 31-Mar-2019 [#Q1]

Stock
[AKRO] Akero Therapeutics, Inc.
Announcement Date
31-Mar-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- 91.28%
YoY- -1,173.63%
Quarter Report
AKRO's Result
AKRO's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -53,344 -25,831 -26,029 -15,090 -11,886 -5,362 -421 123.94%
Tax -42 -2,465 -22 -50 -1,237 -5,362 -421 -31.87%
NP -53,344 -23,366 -26,007 -15,090 -11,886 -5,362 -421 123.94%
Tax Rate - - - - - - - -
Total Cost 53,344 23,366 26,007 15,090 11,886 5,362 421 123.94%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
EPS -0.90 -0.50 -0.74 -0.43 -0.42 -0.20 -0.02 88.48%
EPS Diluted -0.90 -0.50 -0.74 -0.43 -0.42 -0.20 -0.02 88.48%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.